Newsletter

141080 - LigaChem Biosciences Inc.

141080 Summary
Biopharma
Stock Price & Overview
₩92,000 +3,700 (+4.19%) Close · Sep 4, 2026 KST
KOSDAQ | ₩KRW | Close: ₩92,000  ≈ US$66  ·  Market cap ₩3.4tn (≈ $2.4bn)
What kstock analysis is. It reads the Korean news and the DART filing, checks the numbers against the source, and explains what changed and what to watch. It does not issue buy, sell or hold ratings and it does not set price targets. Why not »

141080 Analysis

ks

LigaChem Biosciences: It Is Now Paying To Keep A Drug It Co-Owned

LigaChem Biosciences Inc. (KOSDAQ:141080) signed a contract on August 7 taking sole development and out-licensing rights to LNCB74, a B7-H4 antibody-drug conjugate it had been developing jointly with NextCure.

kstock researchSep 2, 1:28 AMADCSave
1 piece. Written with AI assistance from Korean-language sources; each links the article it rests on.

Similar to 141080

SymbolLast Price
028300HLB Co., Ltd.₩33,750
+2.9%
298380ABL Bio Inc.₩71,400
+5.6%
000250Samchundang Pharm₩157,000
+1.0%
087010Peptron, Inc.₩157,300
+7.3%
145020Hugel, Inc.₩244,000
+1.5%
302440SK Bioscience Co., Ltd.₩37,900
+0.4%
009420Hanall Biopharma Co., Ltd.₩54,700
+1.5%
310210Voronoi, Inc.₩153,000
+3.9%
214370Caregen Co., Ltd.₩44,500
+1.5%
347850D & D Pharmatech, Inc.₩49,200
+1.4%
Compare all 48 in Biopharma

What a US investor should know

  • Trading hours09:00–15:30 KST — 20:00–02:30 US Eastern the night before.
  • Daily limitKorean stocks can move at most ±30% in a session before trading halts.
  • Getting exposureKRX shares are not directly tradable in most US brokerage accounts. The usual routes are Korea ETFs or an international account.
  • ReportingKorean issuers file to DART, not the SEC. Half-year and quarterly reports land about 45 days after period end.